pubmed.ncbi.nlm.nih.gov

Prospects for malaria eradication in sub-Saharan Africa - PubMed

  • ️Tue Jan 01 2008

Prospects for malaria eradication in sub-Saharan Africa

Ricardo Aguas et al. PLoS One. 2008.

Abstract

Background: A characteristic of Plasmodium falciparum infections is the gradual acquisition of clinical immunity resulting from repeated exposures to the parasite. While the molecular basis of protection against clinical malaria remains unresolved, its effects on epidemiological patterns are well recognized. Accumulating epidemiological data constitute a valuable resource that must be intensively explored and interpreted as to effectively inform control planning.

Methodology/principal finding: Here we apply a mathematical model to clinical data from eight endemic regions in sub-Saharan Africa. The model provides a quantitative framework within which differences in age distribution of clinical disease are assessed in terms of the parameters underlying transmission. The shorter infectious periods estimated for clinical infections induce a regime of bistability of endemic and malaria-free states in regions of mesoendemic transmission. The two epidemiological states are separated by a threshold that provides a convenient measure for intervention design. Scenarios of eradication and resurgence are simulated.

Conclusions/significance: In regions that support mesoendemic transmission, intervention success depends critically on reducing prevalence below a threshold which separates endemic and malaria-free regimes.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Model diagram representing the dynamics of malaria transmission.

The compartments represent the following epidemiological classes: (S) completely susceptible individuals, either newborns, or those who have lost clinical immunity; (I1) clinical malaria cases resulting from infection of completely susceptible individuals; (R) individuals that have recovered from any infection and are clinically immune; (I2) asymptomatic malaria cases resulting from infection of clinically immune individuals.

Figure 2
Figure 2. Endemic stability and bistability.

(A) Prevalence of severe clinical malaria in children less than 10 years of age (grey) and model output (black). The error bars represent a 95% confidence interval. The eight regions are ranked by the estimated forces of infection. (B) Equilibrium proportion of clinical malaria over all ages in terms of R0. The full lines represent the stable solutions of the system of differential equations, whereas the dashed lines stand for unstable equilibria. Endemic equilibria are marked for two representative regions: Foni Kansala and Kilifi. Alternative disease-free equilibria for Foni Kansala is marked F. (C) Relationship between the force of infection (or entomological inoculation rate, EIR) and the parasite prevalence. The full line represents the stable solution of the system whereas the dashed line stands for an unstable equilibrium.

Figure 3
Figure 3. Sensitivity to hospitalisation rate, parameter η.

(A) Equilibrium curves for different values of η (1, 0.6, 0.4, 0.2, from lower to higher peak). (B) Estimated basic reproduction numbers for different values of η. The black full line on the left shows the lower value of R0 for which an endemic equilibrium solution exists. The red and green dotted lines represent the values of R0, derived from the estimated forces of infection, for Foni Kansala and Kilifi, respectively. Circles highlight the values of ηcorresponding to the curves in (A).

Figure 4
Figure 4. Parameter region for the existence of bistability.

The grey area represents the region of parameters in which bistability is obtained. The darker grey area defines the conditions for bistability in Foni Kansala.

Similar articles

Cited by

References

    1. Snow RW, Guerra C, Noor A, Myint H, Hay S. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005;434:214–217. - PMC - PubMed
    1. Snow RW, Craig M, Deichmann U, Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population, Bull World Health Organ. 77. 1999 - PMC - PubMed
    1. Bull PC, Marsh K. The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria. Trends Microbiol. 2002;10:55–58. - PubMed
    1. Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature. 2002;415:673–679. - PubMed
    1. Rogier C, Ly AB, Tall A, Cisse B, Trape JF. Plasmodium falciparum clinical malaria in Dielmo, a holoendemic area in Senegal: no influence of acquired immunity on initial symptomatology and severity of malaria attacks. Am J Trop Med Hyg. 1999;60:410–420. - PubMed

Publication types

MeSH terms